124 related articles for article (PubMed ID: 21548334)
1. [Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection].
Herych ID; Vashchuk VV
Klin Khir; 2011 Feb; (2):65-9. PubMed ID: 21548334
[No Abstract] [Full Text] [Related]
2. [Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
Boĭko VV; Ivanova IuV
Klin Khir; 2012 Jan; (1):30-2. PubMed ID: 22642085
[TBL] [Abstract][Full Text] [Related]
3. [A randomized controlled clinical trial of sulperazon in the treatment of surgical infection].
Tian Y; Zheng X; Xu Y
Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):740-3. PubMed ID: 9590776
[TBL] [Abstract][Full Text] [Related]
4. A combination regimen of meropenem, cefoperazone-sulbactam and minocycline for extensive burns with pan-drug resistant Acinetobacter baumannii infection.
Ning F; Shen Y; Chen X; Zhao X; Wang C; Rong Y; Du W; Wen C; Zhang G
Chin Med J (Engl); 2014; 127(6):1177-9. PubMed ID: 24622455
[No Abstract] [Full Text] [Related]
5. [Sulperazone in the treatment of severe infections in patients with cancer].
Mitrokhin SD
Antibiot Khimioter; 2003; 48(3):26-9. PubMed ID: 12914118
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
[TBL] [Abstract][Full Text] [Related]
7. Use of cefoperazone/sulbactam in neonates.
Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
[TBL] [Abstract][Full Text] [Related]
8. [Application of gepacef comby for an acute surgical diseases of organs of the hepatopancreatobiliary zone].
Pesotskiĭ ON
Klin Khir; 2013 Jan; (1):40-3. PubMed ID: 23610944
[TBL] [Abstract][Full Text] [Related]
9. [Amoxycillin/Sulbactam (Trifamox IBL) in prophylaxis and therapy of surgical site infections in oncologic patients].
Mitrokhin SD; Sokolov AA
Antibiot Khimioter; 2010; 55(7-8):34-41. PubMed ID: 21140563
[No Abstract] [Full Text] [Related]
10. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
11. Sulbactam-containing beta-lactamase inhibitor combinations.
Akova M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
[TBL] [Abstract][Full Text] [Related]
13. Cefoperazone or cefoperazone-sulbactam as perioperative antibiotic prophylaxis in transurethral surgery.
Nielsen KT; Madsen PO
J Chemother; 1989 Jul; 1(4 Suppl):1010-1. PubMed ID: 16312747
[No Abstract] [Full Text] [Related]
14. The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Guclu E; Kaya G; Ogutlu A; Karabay O
J Chemother; 2020 May; 32(3):118-123. PubMed ID: 32096456
[TBL] [Abstract][Full Text] [Related]
15. [Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
Shi Y; Xu YC; Liu Y; Du W; Rui X; Wang Y
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2847-50. PubMed ID: 23290215
[TBL] [Abstract][Full Text] [Related]
16. [Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
Antibiot Khimioter; 2006; 51(1):14-7. PubMed ID: 16734360
[TBL] [Abstract][Full Text] [Related]
17. Pacemaker pocket infection associated with septicemia caused by Pseudomonas aeruginosa.
Nandhakumar B; Menon T; Ravishankar G; Shanmugasundaram S
Int J Infect Dis; 2008 Jan; 12(1):107-8. PubMed ID: 17587621
[No Abstract] [Full Text] [Related]
18. The role of cefoperazone-sulbactam for treatment of severe melioidosis.
Apisarnthanarak A; Little JR
Clin Infect Dis; 2002 Mar; 34(5):721-3. PubMed ID: 11823963
[No Abstract] [Full Text] [Related]
19. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Huang JJ; Zeng Q; Yu JL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
